Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Sales | 1,222 | 344 | 7,227 | 349 | 434 |
| Gross Profit | 1,222 | 344 | 7,227 | 349 | 434 |
| Operating Expenses | 1,265 | 1,283 | 1,530 | 938 | 1,268 |
| Operating Income | -43 | -939 | 5,697 | -589 | -833 |
| Interest Expense | 0 | 0 | 0 | -47 | 0 |
| Other Income | 2 | -7 | 18 | 136 | 32 |
| Pre-tax Income | -41 | -946 | 5,715 | -406 | -801 |
| Income Tax | 46 | N/A | 492 | -192 | N/A |
| Net Income Continuous | -88 | -946 | 5,223 | -214 | -801 |
| Net Income | $-88 | $-946 | $5,223 | $-214 | $-801 |
| EPS Basic Total Ops | -0.01 | -0.16 | 0.90 | -0.04 | -0.14 |
| EPS Basic Continuous Ops | -0.01 | -0.16 | 0.90 | -0.04 | -0.14 |
| EPS Diluted Total Ops | -0.01 | -0.16 | 0.81 | -0.04 | -0.14 |
| EPS Diluted Continuous Ops | -0.01 | -0.16 | 0.80 | -0.04 | -0.14 |
| EBITDA(a) | $-34 | $-932 | $5,729 | $-582 | $-825 |